What is DES Exposure and Why Does It Still Matter Today?
- May 25
- 7 min read
Claire Silverstone-Bright is an author, speaker and criminology researcher whose work connects lived experience with public education. She is the author of A Life Lived Chronically: Memoir of a DES Daughter and writes on DES, justice and rehabilitation.
DES exposure is often spoken about as if it belongs to medical history. For many of us, it is not history at all. It is a lifelong inheritance carried in our bodies, our fertility stories, our medical records and sometimes in the silence between generations.
There are some medical stories that arrive with sirens. Others move quietly, passed from mother to child, from appointment to appointment, from one unexplained symptom to the next.
DES belongs to the second kind. Diethylstilbestrol, usually known as DES, was a synthetic oestrogen prescribed to pregnant women, particularly between the 1940s and 1970s, in the belief that it could help prevent miscarriage and other pregnancy complications. The tragedy is that it did not protect those pregnancies in the way women were led to believe. Instead, it became one of the clearest examples of how a drug given during pregnancy can have consequences not only for the person taking it, but for the child developing inside her.
For some people, DES is a medical footnote. For others, including me, it is biography. I am a DES daughter. That means I was exposed to DES before I was born. I did not choose it, swallow it, consent to it or even know about it in the beginning. Yet it became part of the architecture of my life.
What is DES?
DES is the common name for diethylstilbestrol, a man made form of oestrogen. It was prescribed to millions of pregnant women around the world before researchers identified serious risks associated with exposure. The National Cancer Institute describes DES as a synthetic form of oestrogen that was prescribed to some pregnant women between about 1940 and 1971 to prevent miscarriage, premature labour and related pregnancy complications.
The first public alarm bell came when DES exposure in the womb was linked to a rare cancer called clear cell adenocarcinoma of the vagina and cervix in young women. The American Cancer Society notes that this cancer remains rare, but that the risk is increased in women exposed to DES before birth.
That word matters. Rare does not mean imaginary. Rare does not mean irrelevant. Rare does not mean acceptable when the risk was created by a medication given to pregnant women without proper understanding of its long term effects.
What does it mean to be DES exposed?
A person with DES exposure may be a DES mother, DES daughter, DES son or potentially a member of the next generation whose health questions are still being studied.
A DES mother is a woman who was prescribed DES during pregnancy. A DES daughter is a woman exposed to DES in the womb. A DES son is a man exposed in the womb. There are also questions about DES grandchildren, although the science here is more complex and still developing.
For DES daughters, the known concerns can include reproductive tract changes, infertility, ectopic pregnancy, miscarriage, premature birth, early menopause and a lifelong need to be attentive to certain cancer risks. The National Cancer Institute notes that DES daughters have increased risks of several health outcomes, including clear cell adenocarcinoma, reproductive tract abnormalities, pregnancy complications and early menopause.
This does not mean every DES daughter will experience every risk. It means the exposure should be known, documented and taken seriously.
That is the quiet cruelty of DES. It can make the body feel like a locked room where the key was lost before birth.
Why is DES still so poorly understood?
One reason DES remains hidden is that many people do not know they were exposed. Some mothers were never told what they were given. Some prescriptions were recorded under brand names. Some medical notes have disappeared. Some families never discussed pregnancy loss, fertility treatment, gynaecological symptoms or the painful private history of trying to have children.
Another reason is that DES sits in an awkward place in public understanding. It is not quite remembered like thalidomide. It is not widely taught as a mainstream women’s health issue. It lives in the margins, despite having affected families across countries and generations.
Even among medical professionals, awareness can vary. A woman may say “I am a DES daughter” and be met with recognition, confusion or a hurried search of the screen. That is not always the fault of an individual doctor. It is often a failure of institutional memory. But when the system forgets, patients have to become archivists of their own bodies.
Why should doctors, influencers and the public care?
Doctors should care because DES exposure can affect screening, diagnosis, fertility history, pregnancy risk and the interpretation of symptoms. It is not enough to treat each symptom as a lonely island. DES can be the map.
Influencers should care because awareness saves people from isolation. A single post can reach someone who has spent decades thinking her health history was simply bad luck, bad nerves, bad timing or bad genes.
The public should care because DES is not only a medical story. It is a trust story. It asks uncomfortable questions. What happens when medicine moves faster than evidence? What happens when women’s bodies become testing grounds? What happens when harm is discovered, but the people affected are left to find one another in fragments? DES matters because it reminds us that “the past” is not past when it is still being lived in bodies.
The emotional impact of DES exposure
Medical harm is often described in clinical language. Risk, incidence, abnormality, outcome. Those words are necessary. They are also incomplete.
To live with DES exposure can mean living with uncertainty. It can mean wondering whether a symptom is ordinary or significant. It can mean attending intimate examinations with a history that requires explanation before care can begin. It can mean carrying fertility grief, pregnancy trauma, surgical histories, cancer anxiety or the strange loneliness of being part of a group many people have never heard of.
It can also affect identity. When something happened to you before you were born, where do you place the anger? The grief? The responsibility? The story?
For me, writing A Life Lived Chronically Memoir of a DES Daughter was part of answering that question. I did not want DES to remain a ghost in the notes, a shadow over symptoms, or a phrase understood only by those already carrying it. I wanted to give it language.
DES is not only a women’s issue
Although DES is often discussed through the experiences of mothers and daughters, it is not only a women’s issue. DES sons may also have health concerns, particularly involving reproductive and genital development. Research into the full effects across exposed populations and future generations continues.
It is also not only a patient issue. It belongs in conversations about medical ethics, pharmaceutical accountability, informed consent, public health communication and gendered medicine. Every DES story is personal. The pattern is public.
What should someone do if they think they were exposed?
Anyone who believes they may have been exposed to DES should try, where possible, to gather family and medical history. This may include asking whether their mother was given medication during pregnancy, checking old records, or discussing the possibility of DES exposure with a GP, gynaecologist or relevant specialist.
It is important not to panic. DES exposure is not a diagnosis of a particular illness. It is a risk factor and a medical history point that deserves informed care.
People who know or suspect they were exposed should ask their clinician what screening or follow up is appropriate for their age, sex, symptoms and medical background. The best care begins when the exposure is not dismissed.
Why I am writing about DES now
I am writing about DES because too many people still do not know what it is.
I am writing because some women have spent their lives being told their pain was mysterious, exaggerated or unrelated.
I am writing because medical history should not be tidied away when the consequences are still unfolding.
I am writing because lived experience has a role in public education. Research matters. Clinical knowledge matters. But testimony also matters. It carries the human weather of the facts.
DES is not simply something that happened. It is something that happened to people.
A call for recognition
The first step is awareness. The second is listening. The third is ensuring that people affected by DES are met with informed care rather than blank looks, disbelief or bureaucratic fog.
If you are a doctor, ask the question. If you are an influencer, share the information. If you are a DES exposed person, know that your story belongs in the room. If you are a reader encountering DES for the first time, let this be the doorway.
Hidden harm does not become less real because it has been poorly remembered. It becomes more urgent. To learn more about my personal experience of DES exposure and its lifelong impact, my memoir A Life Lived Chronically Memoir of a DES Daughter explores the body, memory, family and resilience behind the medical term. It is one story, but it is part of a much larger one. That larger story still needs to be told.
Read more from Claire R. Silverstone-Bright
Claire R. Silverstone-Bright, Author, Expert by Experience and Criminologist
Claire Silverstone-Bright is an author, speaker and criminology researcher working at the intersection of hidden medical harm, justice and rehabilitation. Her memoir, A Life Lived Chronically: Memoir of a DES Daughter, explores the lifelong impact of DES exposure and the wider consequences of being medically harmed, misunderstood and unheard. Through her writing, public speaking and research, Claire examines how identity can be rebuilt after adversity. Her mission is to transform lived experience into public education, compassion and meaningful change.
